Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TUNG T NGUYEN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1013982024
CMS profile
227707
Location
SAN JOSE, CA

General Payments · PY2018–2024

$5,974.22

  • Reported across 293 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,038.79

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,038.79 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $747.67 49
PY2019 $944.70 58
PY2020 $329.38 18
PY2021 $1,200.94 55
PY2022 $974.81 53
PY2023 $737.93 26
PY2024 $1,038.79 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AIMMUNE THERAPEUTICS, INC. $32.50 01/10/2024 Food and Beverage Undisputed 01/23/2026 1147018346 CMS
AIMMUNE THERAPEUTICS, INC. $32.18 02/07/2024 Food and Beverage Undisputed 01/23/2026 1146965952 CMS
AIMMUNE THERAPEUTICS, INC. $33.22 03/06/2024 Food and Beverage Undisputed 01/23/2026 1147018152 CMS
AstraZeneca Pharmaceuticals LP $18.30 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105650642 CMS
AstraZeneca Pharmaceuticals LP $122.02 02/14/2024 Food and Beverage Undisputed 01/23/2026 1105450445 CMS
AstraZeneca Pharmaceuticals LP $123.31 03/21/2024 Food and Beverage Undisputed 01/23/2026 1104495024 CMS
AstraZeneca Pharmaceuticals LP $13.11 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105818299 CMS
AstraZeneca Pharmaceuticals LP $13.47 04/26/2024 Food and Beverage Undisputed 01/23/2026 1105586322 CMS
AstraZeneca Pharmaceuticals LP $31.04 06/11/2024 Food and Beverage Undisputed 01/23/2026 1104232715 CMS
AstraZeneca Pharmaceuticals LP $103.85 06/12/2024 Food and Beverage Undisputed 01/23/2026 1104765990 CMS
AstraZeneca Pharmaceuticals LP $14.09 06/27/2024 Food and Beverage Undisputed 01/23/2026 1105891602 CMS
AstraZeneca Pharmaceuticals LP $21.72 07/31/2024 Food and Beverage Undisputed 01/23/2026 1105377831 CMS
AstraZeneca Pharmaceuticals LP $16.06 09/03/2024 Food and Beverage Undisputed 01/23/2026 1104244207 CMS
AstraZeneca Pharmaceuticals LP $21.80 09/09/2024 Food and Beverage Undisputed 01/23/2026 1104388439 CMS
AstraZeneca Pharmaceuticals LP $18.67 10/25/2024 Food and Beverage Undisputed 01/23/2026 1104775522 CMS
AstraZeneca Pharmaceuticals LP $14.07 11/04/2024 Food and Beverage Undisputed 01/23/2026 1105511177 CMS
AstraZeneca Pharmaceuticals LP $22.62 11/08/2024 Food and Beverage Undisputed 01/23/2026 1104615526 CMS
AstraZeneca Pharmaceuticals LP $18.20 11/15/2024 Food and Beverage Undisputed 01/23/2026 1105585790 CMS
GlaxoSmithKline, LLC. $25.12 06/12/2024 Food and Beverage Undisputed 01/23/2026 1116603552 CMS
GlaxoSmithKline, LLC. $27.03 08/07/2024 Food and Beverage Undisputed 01/23/2026 1116446402 CMS
Merck Sharp & Dohme LLC $27.24 05/15/2024 Food and Beverage Undisputed 01/23/2026 1141741462 CMS
Merck Sharp & Dohme LLC $29.14 08/14/2024 Food and Beverage Undisputed 01/23/2026 1141881103 CMS
Novartis Pharmaceuticals Corporation $29.03 02/21/2024 Food and Beverage Undisputed 01/23/2026 1087152446 CMS
Novartis Pharmaceuticals Corporation $29.65 03/13/2024 Food and Beverage Undisputed 01/23/2026 1087152448 CMS
Novartis Pharmaceuticals Corporation $30.10 07/03/2024 Food and Beverage Undisputed 01/23/2026 1087152456 CMS
Novartis Pharmaceuticals Corporation $1.22 07/03/2024 Food and Beverage Undisputed 01/23/2026 1087152458 CMS
Novartis Pharmaceuticals Corporation $21.79 07/24/2024 Food and Beverage Undisputed 01/23/2026 1087152464 CMS
Novartis Pharmaceuticals Corporation $25.45 10/30/2024 Food and Beverage Undisputed 01/23/2026 1087152472 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.54 09/05/2024 Food and Beverage Undisputed 01/23/2026 1153592647 CMS
Xeris Pharmaceuticals, Inc. $21.95 02/28/2024 Food and Beverage Undisputed 01/23/2026 1144616409 CMS
Xeris Pharmaceuticals, Inc. $24.12 03/20/2024 Food and Beverage Undisputed 01/23/2026 1144616411 CMS
Xeris Pharmaceuticals, Inc. $18.32 04/10/2024 Food and Beverage Undisputed 01/23/2026 1144616413 CMS
Xeris Pharmaceuticals, Inc. $20.61 05/08/2024 Food and Beverage Undisputed 01/23/2026 1144616415 CMS
Xeris Pharmaceuticals, Inc. $24.25 12/18/2024 Food and Beverage Undisputed 01/23/2026 1144616417 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.